ICCC Stock Analysis: Buy, Sell, or Hold?
ICCC - Immucell Corp
$10.06
-0.03 (-0.30%)
▼
5d:
+0.1%
30d:
-7.96%
90d:
+0.5%
BUY
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When ICCC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ICCC shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: ICCC shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ICCC is currently trading at $10.06, which is considered oversold relative to its 30-day fair value range of $10.35 to $11.32.
Technical Outlook: Technically, ICCC is in a strong uptrend. Immediate support is located at $9.55, while resistance sits at $11.14.
Market Sentiment: ICCC scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+39.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ICCC is in a strong uptrend. Immediate support is located at $9.55, while resistance sits at $11.14.
Market Sentiment: ICCC scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $14.00 (+39.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.35 -
$11.32
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 39.2% below Wall St target ($14.00)
- BULLISH: Bottoming setup score 63/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$10.35 -
$11.32
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.55
Resistance Level
$11.14
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Wall Street Target
$14.00
(+39.2%)
Revenue Growth (YoY)
11.5%
Earnings Growth (YoY)
259.9%
Profit Margin
2.6%
Share & Embed Analysis
Last updated: August 22, 2026 12:40 PM ET
Data refreshes hourly during market hours. Next update: 1:40 PM
Data refreshes hourly during market hours. Next update: 1:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICCC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 33 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1100 | 43 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 39 SELL |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 26 SELL |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
